Complete financial analysis of MedFirst Healthcare Services, Inc. (4175.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MedFirst Healthcare Services, Inc., a leading company in the Healthcare industry within the Healthcare sector.
- CFM Indosuez Wealth Management SA (MLCFM.PA) Income Statement Analysis – Financial Results
- CNOOC Energy Technology & Services Limited (600968.SS) Income Statement Analysis – Financial Results
- Cayson Acquisition Corp Unit (CAPNU) Income Statement Analysis – Financial Results
- Boxxy Inc. (BXXY) Income Statement Analysis – Financial Results
- The Chemours Company (CC) Income Statement Analysis – Financial Results
MedFirst Healthcare Services, Inc. (4175.TWO)
About MedFirst Healthcare Services, Inc.
MedFirst Healthcare Services, Inc. engages in the sale of medical supplies in Taiwan and China. It offers diabetes care products; respiratory treatment; incontinence and wound dressing; medical devices; ostomy care; pain relief products; supplements; rehabilitation products; and homecare, childcare, and maternal products. The company also offers healthcare products consist of beauty care, makeup, and food and beverage products. In addition, it operates as a contractor for medical supply sales department of hospitals; and agent for foreign medical supplies brand; trading of water ionizers; provides laundry service; and prescription drug service. Further, the company is involved in the management of hospital shopping malls. It sells products through its retail stores and online. MedFirst Healthcare Services, Inc. was founded in 1990 and is headquartered in Taoyuan City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 7.45B | 7.22B | 6.54B | 5.93B | 5.30B |
| Cost of Revenue | 5.18B | 5.02B | 4.61B | 4.10B | 3.66B |
| Gross Profit | 2.27B | 2.21B | 1.93B | 1.82B | 1.64B |
| Gross Profit Ratio | 30.47% | 30.53% | 29.46% | 30.78% | 30.97% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 462.05M | 415.17M | 380.77M | 371.82M | 314.95M |
| Selling & Marketing | 1.70B | 1.56B | 1.43B | 1.30B | 1.15B |
| SG&A | 2.16B | 1.98B | 1.81B | 1.67B | 1.47B |
| Other Expenses | 0.00 | 37.93M | -18.64M | 1.55M | 0.00 |
| Operating Expenses | 2.16B | 1.98B | 1.81B | 1.67B | 1.47B |
| Cost & Expenses | 7.34B | 7.00B | 6.43B | 5.77B | 5.13B |
| Interest Income | 8.47M | 3.12M | 1.79M | 2.30M | 1.89M |
| Interest Expense | 58.43M | 46.80M | 37.40M | 24.68M | 14.35M |
| Depreciation & Amortization | 745.00M | 673.23M | 591.07M | 509.81M | 87.45M |
| EBITDA | 873.32M | 940.99M | 686.17M | 666.89M | 261.62M |
| EBITDA Ratio | 11.73% | 13.03% | 10.49% | 11.25% | 4.93% |
| Operating Income | 105.09M | 267.76M | 95.10M | 157.08M | 174.16M |
| Operating Income Ratio | 1.41% | 3.71% | 1.45% | 2.65% | 3.28% |
| Total Other Income/Expenses | -35.20M | -4.76M | -52.99M | -22.62M | 4.58M |
| Income Before Tax | 69.89M | 221.96M | 58.96M | 130.62M | 178.74M |
| Income Before Tax Ratio | 0.94% | 3.07% | 0.90% | 2.20% | 3.37% |
| Income Tax Expense | 22.36M | 46.28M | -7.33M | 26.17M | 38.53M |
| Net Income | 46.80M | 170.86M | 67.93M | 109.85M | 141.03M |
| Net Income Ratio | 0.63% | 2.37% | 1.04% | 1.85% | 2.66% |
| EPS | 1.13 | 4.41 | 1.80 | 2.96 | 3.98 |
| EPS Diluted | 1.11 | 4.09 | 1.69 | 2.75 | 3.75 |
| Weighted Avg Shares Out | 41.55M | 38.77M | 37.73M | 37.14M | 37.59M |
| Weighted Avg Shares Out (Dil) | 42.35M | 42.42M | 42.29M | 40.97M | 37.99M |
Source: https://incomestatements.info
Category: Stock Reports